Page last updated: 2024-08-16

trimethoprim and carbapenems

trimethoprim has been researched along with carbapenems in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (14.29)18.2507
2000's0 (0.00)29.6817
2010's2 (28.57)24.3611
2020's4 (57.14)2.80

Authors

AuthorsStudies
Curty, LK; Epp, SF; Köhler, T; Pechère, JC1
De Smet, B; Jacobs, J; Kham, C; Koole, O; Kruy, L; Lynen, L; Phe, T; Thai, S; Veng, CH; Vlieghe, E1
Dance, D1
Bao, M; Fu, Y; Li, C; Su, S; Wang, Y; Yu, L; Zhang, J; Zhang, X; Zhao, Y1
Nathanson, BH; Shorr, AF; Sulham, K; Zilberberg, MD1
Becerra-Aparicio, F; Fuchs, F; Higgins, PG; Seifert, H; Xanthopoulou, K1
Aiesh, BM; Maali, Y; Omarya, S; Qandeel, F; Sabateen, A; Sholi, S; Taha, AA; Taha, SA; Zyoud, SH1

Reviews

1 review(s) available for trimethoprim and carbapenems

ArticleYear
Treatment and prophylaxis of melioidosis.
    International journal of antimicrobial agents, 2014, Volume: 43, Issue:4

    Topics: Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Burkholderia pseudomallei; Carbapenems; Ceftazidime; Clavulanic Acid; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Infusions, Parenteral; Melioidosis; Sulfamethoxazole; Trimethoprim

2014

Other Studies

6 other study(ies) available for trimethoprim and carbapenems

ArticleYear
Characterization of MexT, the regulator of the MexE-MexF-OprN multidrug efflux system of Pseudomonas aeruginosa.
    Journal of bacteriology, 1999, Volume: 181, Issue:20

    Topics: 4-Quinolones; Anti-Infective Agents; Bacterial Outer Membrane Proteins; Biological Transport, Active; Carbapenems; Chloramphenicol; Cloning, Molecular; Drug Resistance, Multiple; Gene Expression Regulation, Bacterial; Genes, Bacterial; Molecular Sequence Data; Mutation; Operon; Phenotype; Porins; Pseudomonas aeruginosa; RNA Processing, Post-Transcriptional; Sequence Analysis, DNA; Transcription, Genetic; Trimethoprim

1999
Melioidosis, phnom penh, Cambodia.
    Emerging infectious diseases, 2011, Volume: 17, Issue:7

    Topics: Adolescent; Adult; Aged; Burkholderia pseudomallei; Cambodia; Carbapenems; Cephalosporins; Diabetes Mellitus, Type 2; Diagnostic Errors; Doxycycline; Female; Humans; Male; Melioidosis; Microbial Sensitivity Tests; Middle Aged; Risk Factors; Sulfamethoxazole; Survival Rate; Trimethoprim

2011
Outbreak of KPC-2-Producing
    Microbial drug resistance (Larchmont, N.Y.), 2020, Volume: 26, Issue:9

    Topics: Adhesins, Bacterial; Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; China; Conjugation, Genetic; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gene Expression; Genome, Bacterial; Hospital Units; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing; Neurosurgery; Plasmids; Sulfonamides; Trimethoprim; Whole Genome Sequencing

2020
Multiple antimicrobial resistance and outcomes among hospitalized patients with complicated urinary tract infections in the US, 2013-2018: a retrospective cohort study.
    BMC infectious diseases, 2021, Feb-08, Volume: 21, Issue:1

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Chronic Disease; Drug Combinations; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Hospitalization; Humans; Male; Middle Aged; Retrospective Studies; Risk Factors; Sulfadoxine; Trimethoprim; United States; Urinary Tract Infections

2021
In vitro activity of nitroxoline against carbapenem-resistant Acinetobacter baumannii isolated from the urinary tract.
    The Journal of antimicrobial chemotherapy, 2022, 06-29, Volume: 77, Issue:7

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Ciprofloxacin; Escherichia coli; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Nitroquinolines; Sulfamethoxazole; Trimethoprim; Urinary Tract; Urinary Tract Infections

2022
Epidemiology and clinical characteristics of patients with carbapenem-resistant enterobacterales infections: experience from a large tertiary care center in a developing country.
    BMC infectious diseases, 2023, Oct-02, Volume: 23, Issue:1

    Topics: Amikacin; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross-Sectional Studies; Developing Countries; Escherichia coli; Female; Humans; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia; Retrospective Studies; Sulfamethoxazole; Tertiary Care Centers; Trimethoprim

2023